ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
103,427.75
-0.67%
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs Yen
156.295
0.00%
Brent Oil
80.005
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Inovio Pharmaceuticals Inc New (INO) 銘柄情報

Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc New (INO)

Inseego Corp
2.08
0.17
(8.90%)
終了 1月18日 6:00AM
15分遅延
2.08
0.00
(0.00%)
取引時間後: 9:37AM
15分遅延

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
2.08
買値
2.08
売値
2.09
出来高
917,788
1.90 日の範囲 2.105
1.74 52 週間の範囲 14.748
時価総額
54.288M
前日終値
1.91
始値
1.94
時刻
200
@
2.08
(formt)
最終取引時間
財務取引量
US$ 1,850,650
VWAP
2.0164
平均取引量 (3 か月)
942,289
発行済株式数
26,099,991
配当利回り
-
PER
-0.40
1 株当たり利益 (EPS)
-5.18
歳入
832k
純利益
-135.12M

Inovio Pharmaceuticals Inc New について

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and... Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. 詳細を表示

セクター
Surgical,med Instr,apparatus
業界
Surgical,med Instr,apparatus
ウェブサイト
www.inovio.com
本社
Wilmington, Delaware, USA
設立
-
Inovio Pharmaceuticals Inc New is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker INO. The last closing price for Inovio Pharmaceuticals was US$1.91. Over the last year, Inovio Pharmaceuticals shares have traded in a share price range of US$ 1.74 to US$ 14.748.

Inovio Pharmaceuticals currently has 26,099,991 shares in issue. The market capitalisation of Inovio Pharmaceuticals is US$49.85 million. Inovio Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.40.

INO 最新ニュース

その他のニュース

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments PR Newswire PLYMOUTH MEETING, Pa., Jan. 9, 2025 PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ:...

2025年1月9日
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月19日
Edgar (US Regulatory)

Form 8-K - Current report

2024年12月16日
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

2024年12月14日
Edgar (US Regulatory)

INOVIO Announces Pricing of $30 Million Public Offering

INOVIO Announces Pricing of $30 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 13, 2024 PLYMOUTH MEETING, Pa., Dec. 13, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq:...

2024年12月13日
PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]

2024年12月13日
Edgar (US Regulatory)

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 12, 2024 PLYMOUTH MEETING, Pa., Dec. 12, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a...

2024年12月13日
PR Newswire (US)

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial PR Newswire PLYMOUTH MEETING...

2024年12月3日
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Nov. 29, 2024 PLYMOUTH MEETING, Pa., Nov. 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

2024年11月30日
PR Newswire (US)

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., Nov. 14, 2024 New immunology data for INO-3107 supporting proposed mechanism...

2024年11月15日
PR Newswire (US)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.052.463054187192.032.10011.817623641.90893768CS
40.2513.66120218581.832.391.7512427631.98200549CS
12-3.6-63.38028169015.685.81.749422892.72957314CS
26-8.98-81.193490054211.0612.331.745900264.07167547CS
52-6.464-75.65543071168.54414.7481.745936106.55287075CS
156-53.84-96.280400572255.9256.11.74389043417.92926453CS
260-39.2-94.961240310141.284261.749155111122.26095195CS

INO - Frequently Asked Questions (FAQ)

What is the current Inovio Pharmaceuticals share price?
The current share price of Inovio Pharmaceuticals is US$ 2.08
How many Inovio Pharmaceuticals shares are in issue?
Inovio Pharmaceuticals has 26,099,991 shares in issue
What is the market cap of Inovio Pharmaceuticals?
The market capitalisation of Inovio Pharmaceuticals is USD 49.85M
What is the 1 year trading range for Inovio Pharmaceuticals share price?
Inovio Pharmaceuticals has traded in the range of US$ 1.74 to US$ 14.748 during the past year
What is the PE ratio of Inovio Pharmaceuticals?
The price to earnings ratio of Inovio Pharmaceuticals is -0.4
What is the cash to sales ratio of Inovio Pharmaceuticals?
The cash to sales ratio of Inovio Pharmaceuticals is 65.52
What is the reporting currency for Inovio Pharmaceuticals?
Inovio Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Inovio Pharmaceuticals?
The latest annual turnover of Inovio Pharmaceuticals is USD 832k
What is the latest annual profit for Inovio Pharmaceuticals?
The latest annual profit of Inovio Pharmaceuticals is USD -135.12M
What is the registered address of Inovio Pharmaceuticals?
The registered address for Inovio Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Inovio Pharmaceuticals website address?
The website address for Inovio Pharmaceuticals is www.inovio.com
Which industry sector does Inovio Pharmaceuticals operate in?
Inovio Pharmaceuticals operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

INO Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
INO
Inovio Pharmaceuticals
LSE
RB54
Stan.ch.bk. 28
TSXV
ATE
Antibe Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有